Skip to content
← Back to this collection

PUBLICATIONS · 23704089

Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2013 Jul 4
First author
Creutzig U

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Creutzig U
      type
      Author
    2. name
      Zimmermann M
      type
      Author
    3. name
      Bourquin JP
      type
      Author
    4. name
      Dworzak MN
      type
      Author
    5. name
      Fleischhack G
      type
      Author
    6. name
      Graf N
      type
      Author
    7. name
      Klingebiel T
      type
      Author
    8. name
      Kremens B
      type
      Author
    9. name
      Lehrnbecher T
      type
      Author
    10. name
      von Neuhoff C
      type
      Author
    11. name
      Ritter J
      type
      Author
    12. name
      Sander A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Creutzig U
      type
      Author
    2. name
      Zimmermann M
      type
      Author
    3. name
      Bourquin JP
      type
      Author
    4. name
      Dworzak MN
      type
      Author
    5. name
      Fleischhack G
      type
      Author
    6. name
      Graf N
      type
      Author
    7. name
      Klingebiel T
      type
      Author
    8. name
      Kremens B
      type
      Author
    9. name
      Lehrnbecher T
      type
      Author
    10. name
      von Neuhoff C
      type
      Author
    11. name
      Ritter J
      type
      Author
    12. name
      Sander A
      type
      Author
    bibliography ids
    1. nci-bib-5660836b0291533f45e041ab
    book metadata
    content sha256
    9034e037a44daa52ad9519792fca25482d9f87efac90c5f9a0efe84df64afd09
    document type
    citation
    dois
    1. 10.1182/blood-2013-02-484097
    electronic publication date
    display
    2013 May 23
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23704089
    immutable id
    pubmed:23704089@9034e037a44daa52ad9519792fca25482d9f87efac90c5f9a0efe84df64afd09
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    1
    name
    Blood
    nlm unique id
    7603509
    pages
    37-43
    volume
    122
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23704089
      provenance
      batch id
      99e008dabc339d38fd44
      provider
      NCBI PubMed ESummary
      record sha256
      0c4f38cbcefbf7edf976cc6b078cccce9769545f0201e60b157aef90099c7112
      response sha256
      804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
      retrieved at
      2026-09-09T23:46:55.094762+00:00
      publication date
      display
      2013 Jul 4
      precision
      day
      year
      2013
      publication types
      1. Comparative Study
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23704089/
      title
      Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004.

      Preserved source evidence · Not medical advice